Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-408-2 | CAS number: 527-09-3
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Remarks:
- Dermal Toxicokinetic
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Study period:
- 2018
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
Data source
Materials and methods
- Objective of study:
- absorption
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 417 (Toxicokinetics)
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 428
- GLP compliance:
- no
Test material
- Reference substance name:
- Copper di-D-gluconate
- EC Number:
- 208-408-2
- EC Name:
- Copper di-D-gluconate
- Cas Number:
- 527-09-3
- Molecular formula:
- C12H22CuO14
- IUPAC Name:
- copper(2+) bis(2,3,4,5,6-pentahydroxyhexanoate)
- Test material form:
- solid
Constituent 1
Test animals
- Species:
- other: Human, Human skin and rats, human skin preparations (surgically removed skin from the abdomen), pig, rabbit, rat.
Administration / exposure
- Route of administration:
- dermal
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Taking into account the OECD 417 and the OECD 428, the values obtained with QSAR Toolbox (QT) are reported as % of absorption.
The calculated value reported is 1.42% of absorption; considering the standards, the model is made of skin from which the substance in question is used from 1 to 5 mg / cm2. This means that, if we assume a scenario where a human being of 80 Kg of weight, with an approximate skin extension of 2m2, and an exposure level of 5mg / cm2 (worse of the scenarios paragraph 15 guide 428); the study subject will have an absorption level of 17.75 mg / Kg.
If we compare this value with the lethal dermal dose (2130 mg/Kg), the dose obtained from the absorption in a total exposure in contact with the skin is not representative of a risk.
Applicant's summary and conclusion
- Conclusions:
- The calculated value reported is 1.42% of absorption; considering the standards, the model is made of skin from which the substance in question is used from 1 to 5 mg / cm2. This means that, if we assume a scenario where a human being of 80 Kg of weight, with an approximate skin extension of 2m2, and an exposure level of 5mg / cm2 (worse of the scenarios paragraph 15 guide 428); the study subject will have an absorption level of 17.75 mg / Kg.
If we compare this value with the lethal dermal dose (2130 mg/Kg), the dose obtained from the absorption in a total exposure in contact with the skin is not representative of a risk.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
